FDA Inspection 866757 — Joseph L. Lillo, D.O.
The FDA completed an inspection of Joseph L. Lillo, D.O. on February 26, 2014 in Phoenix, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 26, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Phoenix, AZ (United States)
Additional Details
Clinical Investigator (CI)